Overview of Dr. Hershman

Dr. Dawn Hershman is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 23 years. Dr. Hershman accepts several types of health insurance, listed below. She is one of 62 doctors at New York-Presbyterian Hospital and one of 21 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Hematology. She has more than 100 publications and over 500 citings.

Education & Training

• New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1998 - 2001

• Columbia University School of Public HealthMSc, Biostatistics, 2001

• New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1994 - 1998

• Albert Einstein College of MedicineClass of 1994

• University of California, Los AngelesB.A., Psychology, 1987

Certifications & Licensure

• FL State Medical License 2022 - Present

• NY State Medical License 1995 - 2025

• NJ State Medical License 2022 - 2025

• American Board of Internal Medicine Internal Medicine
• American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

• Top Doctors: New York Metro Area Castle Connolly, 2011-2014
• Breast Cancer Medical Advancement Award AVON, 2010
• Leadership Development Program Awardee ASCO, 2009
• Join now to see all

Clinical Trials

Publications & Presentations

PubMed

• Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy.

  Chen, L., De Meritens, A., St Clair, C., Hou, J., Pua, T., Dioun, S., Khoury-Collado, F., Hershman, D., Wright, J.> ;Gynecologic Oncology. 2024 Jan 22

• Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer.

  Accordino, M., Lee, S., Leu, C., Levin, B., Trivedi, M., Crew, K., Kalinsky, K., Raghunathan, R., Faheem, K., Harden, E., Taboada, A., de Oliveira, B., Larson, E., Fra...> ;Breast Cancer Research and Treatment. 2024 Feb 1

• Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer.

  Yukio Suzuki, Ling Chen, Jennifer S Ferris, Caryn M St Clair, June Y Hou, Alexandre Buckley de Meritens, Khoury-Collado, F., Pua, T., Accordino, M., Hershman, D., Wrig...> ;Gynecologic Oncology. 2024 Jan 1
• Join now to see all

Journal Articles

• Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women with Early-Stage Breast CancerA Randomized Clin...  

  Dawn L Hershman, Jillian L Capodice, William H Kreisle, Michael J Fisch, Marianne K Melnik, Alice T Kengla, Carla W Jorgensen, Heather Greenlee, JAMA

• Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement  

  Ligibel JA, Alfano CM, Hershman DL, Ballard RM, Bruinooge SS, Courneya KS, Daniels EC, Demark-Wahnefried W, Frank ES, Goodwin PJ, Irwin ML, Levit LA, McCaskill-Stevens..., J Clin Oncol, 1/31/2015

• Population-based assessment of determining predictors for quality of prostate cancer surveillance  

  Chamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC, Cancer, 1/26/2015
• Join now to see all

Books/Book Chapters

• Gender differences in Medicine 

  Chapter: Cancer Survivorship: Breast and Prostate Cancer 

  Hershman, D. Ritchie, E. Rosner, Z2004

• Diseases of the Breast 

  Chapter: Managing Menopausal Symptoms in Breast Cancer Patients 

  Hershman, D. Loprinzi, CEdition 3rd,2004

• The Paget Foundation for Bone Disorders 

  Chapter: Questions and Answers about Breast Cancer Metastatic to Bone 

  Hershman, D.2001
• Join now to see all

Lectures

• Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105. 

  2019 ASCO Annual Meeting - 6/1/2019

• Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials. 

  2019 ASCO Annual Meeting - 6/1/2019

• Long Term Consequences of Intermittent and Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer 

  1/1/2015
• Join now to see all

Authored Content

Press Mentions

• Acupuncture Relieves Joint Pain in Breast Cancer Patients Taking Hormone TherapyJanuary 12th, 2023

• What’s New in Breast Cancer Research? SABCS 2022 Delivers PlentyDecember 14th, 2022

• Acupuncture Improves AI-Related Joint Pain in Breast Cancer PatientsNovember 17th, 2022

• Join now to see all

Grant Support

• Acupuncture For Aromatase Inhibitor-Related Arthralgias In Breast Cancer PatientsNational Center For Complementary &Alternative Medicine2011–2012
• Determinants And Risks Of Use And Overuse Of Expensive Oncology DrugsNational Cancer Institute2008–2011
• Osteoporosis Prevention In Early Stage Breast CancerNational Cancer Institute2002–2006
• Pilot--Ethnic Neutropenia In African-Americans And Afro-CaribbeansNational Cancer Institute2003
• Pilot--Ethnic Neutropenia In African Americans And Afro-National Cancer Institute2003

Professional Memberships

Hospital Affiliations

Insurance Accepted

• Anthem Blue Access PPO
  Anthem Blue Preferred HMO
  BCBS Blue Card PPO
  BCBS Illinois PPO
  CIGNA HMO
  CIGNA Open Access
  CIGNA PPO
  Empire BCBS HMO
  Empire BCBS PPO
  

  GHI PPO
  Great West PPO
  HIP of New York - Select PPO
  Humana ChoiceCare Network PPO
  MVP Healthcare PPO
  Oxford Health Freedom
  Oxford Health Liberty
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment